# clm_78C2CEAEC57D

subject: Amgen (/record/amgen.md)  
predicate: quarterly_operating_income  
value: 2,660,000,000 United States dollar  
valid_from: 2022-09-30  
valid_to: 2023-03-31  
published: 2022-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_87A3CD3A03BE  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly operating income: 2,660,000,000 United States dollar", as of 2022-09-30 (until 2023-03-31). Claim clm_78C2CEAEC57D, https://asof.is/claim/clm_78C2CEAEC57D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000055/0000318154-22-000055-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815422000055/0000318154-22-000055-index.htm (primary, SEC EDGAR 10-Q Q3 FY2022, published 2022-11-04)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_operating_income | 2,176,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_78C2CEAEC57D](/claim/clm_78C2CEAEC57D.md) | [clm_E5A8056A8B32](/claim/clm_E5A8056A8B32.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.